IP Library Granted Patent US 8,067,463
Granted Patent B2
US 8,067,463 · App. 11/816,607 · Granted Nov 29, 2011

Protease inhibitor precursor synthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,463
App. No.
11/816,607
Granted
Nov 29, 2011
Kind
B2
Abstract

The present invention provides a compound having the structure (I) and processes for the production thereof and the intermediates used in such process.

Claims (47)

1. A compound having the formula (I) or a stereoisomer thereof,

or a salt form thereof.

2. A compound according to claim 1 wherein the compound is one of the following stereoisomers

3. A process for the production of a compound as described in claim 1 comprising submitting a compound having the formula (II)

wherein

X and Y are independently selected from Si and C; and,

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

to alcohol deprotection conditions and submitting the thus formed deprotected intermediate to an intramolecular cyclisation to obtain a compound of formula (I).

4. A process as described in claim 3 further comprising oxidising a compound having the formula (III)

wherein

X and Y are independently selected from Si and C; and,

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

to obtain a compound of formula (II).

5. A process as described in claim 4 further comprising hydroborating a compound having the formula (IV)

wherein

X and Y are independently selected from Si and C; and,

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

and subsequently oxidising the thus formed hydroborated intermediate to obtain a compound of formula (III).

6. A process according to claim 3 , wherein the deprotecting agent is selected from the group consisting of hydrogenolysis reagents, fluoride reagents, acids and bases, preferably, inorganic and organic acids, most preferably sulfonic acids or carboxylic acids.

7. A process according to claim 3 , wherein deprotection takes place in an aqueous solution, optionally comprising one or more organic solvents.

8. A process according to claim 4 , wherein the oxidation is carried out using Swern, Pfitzner-Moffatt or Parikh-Doering conditions.

9. A process for the production of a compound as described in claim 2 comprising submitting a compound having the formula (II)

wherein

X and Y are independently selected from Si and C; and,

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

to alcohol deprotection conditions and submitting the thus formed deprotected intermediate to an intramolecular cyclisation to obtain a compound of formula (I).

10. A process as described in claim 9 further comprising oxidising a compound having the formula (III)

wherein

X and Y are independently selected from Si and C; and,

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

to obtain a compound of formula (II).

11. A process as described in claim 10 further comprising hydroborating a compound having the formula (IV)

wherein

X and Y are independently selected from Si and C; and, R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H and monovalent hydrocarbon radicals;

R 1 and R 2 can be taken together to form a bivalent hydrocarbon radical represented by —R 1 —R 2 —;

R 3 and R 4 can be taken together to form a bivalent hydrocarbon radical represented by —R 3 —R 4 —;

and subsequently oxidising the thus formed hydroborated intermediate to obtain a compound of formula (III).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2015
From: JANSSEN R & D IRELAND
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 035496/0382 →
CHANGE OF NAME Recorded Apr 15, 2015
From: TIBOTEC PHARMACEUTICALS
To: JANSSEN R&D IRELAND
Reel/Frame 035439/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2011
From: LINCLAU, BRUNO
To: UNIVERSITY OF SOUTHAMPTON
Reel/Frame 027054/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2011
From: UNIVERSITY OF SOUTHAMPTON
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 027054/0501 →